Search
for
Sort by
Research 301–330 of 1000+
- Review of oral minoxidil as treatment of hair disorders: in search of the perfect dose
- Change of the diagnostic distribution in applicants to dermatology after COVID ‐19 pandemic: What it whispers to us?
- Ashy Dermatosis
- An Update on Drug-Induced Pigmentation
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Topical absorption and systemic toxicity
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Primary Cicatricial Alopecias
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Sensitization to saw palmetto and minoxidil in separate topical extemporaneous treatments for androgenetic alopecia
- REVIEW OF SO-CALLED ASEPTIC NEUTROPHILIC DERMATOSES
- Effectiveness of low-level laser therapy in lichen planopilaris
- Effect of <i>Ficus carica</i> leaf extract on the gene expression of selected factors in HaCaT cells
- What′s new in cicatricial alopecia?
- FOX FORDYCE DISEASE IN A PREPUBERTAL GIRL
- Immunoregulatory mechanisms and stress hormones in psoriasis (part 1)
- Alopecia Areata
- GEOGRAPHIC TONGUE IN TWO CHILDREN WITH NONPUSTULAR PSORIASIS
- Clinical review 74: Dermatological manifestations of endocrine disorders.
- Comparison of the Treatment Outcome of Oral Tofacitinib with Other Conventional Therapies in Refractory Alopecia Totalis and Universalis: A Retrospective Study
- Experiences From a Combined Dermatology and Rheumatology Clinic
- Cutaneuos findings in patients with predialysis chronic kidney disease
- Immunomodulators in the treatment of cutaneous lymphoma
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Common Dermatologic Disorders in Down Syndrome: Systematic Review
- A systematic review of dermatologic manifestations among adult patients with COVID‐19 diagnosis
- The eye and the skin in endocrine metabolic diseases
- Updates in the understanding and treatments of skin & hair disorders in women of color
- Topical L‐thyroxine: The Cinderella among hormones waiting to dance on the floor of dermatological therapy?
- Reduced serum brain-derived neurotrophic factor in patients with first onset vitiligo